Latest Reports
News Functions
Additional Functions
2 August 2024
Qiagen N.V.
Half-yearly financial report 2024
2 May 2024
Qiagen N.V.
Q1 statement / Q1 financial report 2024
11 March 2024
Qiagen N.V.
Annual financial report 2023
1 November 2023
Qiagen N.V.
Q3 statement / Q3 financial report 2023
10 August 2023
Qiagen N.V.
Half-yearly financial report 2023
5 May 2023
Qiagen N.V.
Q1 statement / Q1 financial report 2023
13 March 2023
Qiagen N.V.
Annual financial report 2022
9 November 2022
Qiagen N.V.
Q3 statement / Q3 financial report 2022
29 July 2022
Qiagen N.V.
Half-yearly financial report 2022
29 April 2022
Qiagen N.V.
Annual financial report 2021
Qiagen N.V.
Q1 statement / Q1 financial report 2022
8 November 2021
Qiagen N.V.
Q3 statement / Q3 financial report 2021
2 August 2021
Qiagen N.V.
Half-yearly financial report 2021
5 May 2021
Qiagen N.V.
Q1 statement / Q1 financial report 2021
5 March 2021
Qiagen N.V.
Annual financial report 2020
2 November 2020
Qiagen N.V.
Q3 statement / Q3 financial report 2020
5 August 2020
Qiagen N.V.
Half-yearly financial report 2020
8 May 2020
Qiagen N.V.
Q1 statement / Q1 financial report 2020
2 March 2020
Qiagen N.V.
Annual financial report 2019
31 October 2019
Qiagen N.V.
Q3 statement / Q3 financial report 2019
1 August 2019
Qiagen N.V.
Half-yearly financial report 2019
8 May 2019
Qiagen N.V.
Q1 statement / Q1 financial report 2019
6 March 2019
Qiagen N.V.
Annual financial report 2018
31 October 2018
Qiagen N.V.
Q3 statement / Q3 financial report 2018
1 August 2018
Qiagen N.V.
Half-yearly financial report 2018
7 May 2018
Qiagen N.V.
Q1 statement / Q1 financial report 2018
6 March 2018
Qiagen N.V.
Annual financial report 2017
8 November 2017
Qiagen N.V.
Q3 statement / Q3 financial report 2017
31 July 2017
Qiagen N.V.
Half-yearly financial report 2017
4 May 2017
Qiagen N.V.
Q1 statement / Q1 financial report 2017
Latest News
News Functions
Additional Functions
3 September 2024
Qiagen N.V.
QIAGEN N.V.: QIAGEN N.V. launches non-US offering of net share settled convertible bonds
7 January 2024
Qiagen N.V.
QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase
9 November 2022
Qiagen N.V.
Release of a capital market information
3 November 2022
Qiagen N.V.
Qiagen N.V.: Elizabeth E. Tallett, Release of 457 Restricted Stock Units based on grant made on October 31, 2012. Exercise Price: $0.00. Closing price on October 31, 2022: $43.56. Subsequent to …
Qiagen N.V.
Qiagen N.V.: Dr. Metin Colpan, Release of 457 Restricted Stock Units based on grant made on October 31, 2012. Exercise Price: $0.00. Closing price on October 31, 2022: $43.56. Subsequent to the …
2 November 2022
Qiagen N.V.